Elekta (STO:EKTA B) said it and its MRI tech partner Royal Philips (NYSE:PHG) began installation of an investigational high-field MR-adaptive linear accelerator system at Wisconsin’s Froedtert & MCW Clinical Cancer Center at the Froedtert Hospital. Get the full story at our sister site, Medical Design & Outsourcing.
Radiosurgery/Radiation therapy
ViewRay wins CE mark for MRIdian Linac scanner
ViewRay (NSDQ:VRAY) said today it won CE Mark approval in the European Union for its MRIdian Linac next-gen linear accelerator-based MRI-guided radiation therapy system. The newly cleared MRIdian Linac device replaces the cobalt it utilized with linear accelerator technology, Cleveland-based ViewRay said. “We are excited to have CE Mark approval and to begin selling MRIdian Linac within Europe. […]
Novocure touts long-term analysis of Optune drug-device combo
Novocure (NSDQ: NVCR) touted a long-term analysis of data from a Phase III pivotal trial of its Optune device in combination with temozolomide for the treatment of newly-formed glioblastomas. Survival data for nearly 700 patients confirmed interim results from the trial, 1st published in December 2015 in the Journal of the American Medical Assn. Patients treated […]
Varian Medical buys Polish distributor
Varian Medical (NYSE:VAR) said yesterday that it acquired Polish distributor Candela for an undisclosed amount. Warsaw-based Candela, which employs 40 workers, was Varian’s distributor in Poland for 20 years. The deal closed yesterday after Polish anti-trust regulators OKed the transaction. “By bringing Candela’s radiotherapy business into the Varian family we hope to serve our Polish customers […]
Proton therapy demand wave drives expansion of Belgium’s IBA
(Reuters) – When Yves Jongen stood at the controls of his proton therapy machine 15 years ago to treat a cancer patient for the first time he was petrified. Now Jongen’s company IBA is hiring 400 engineers to cope with demand for the technology, increasing its workforce by a third, and expanding its production capacity to […]
Lantheus deals Australian radiopharmacy supply biz to GMS
Lantheus Medical Imaging (NSDQ:LNTH) said yesterday it is selling its Australian radiopharmacy servicing business to Global Medical Solutions. As part of the deal, Lantheus and GMS entered into a long-term supply and distribution contract, with Lantheus supplying GMS and its affiliates with its products, with associated product purchase commitments. “This transaction simplifies our service and […]
Accuray wins FDA nod for Radixact image-guided radiotherapy
Accuray (NSDQ:ARAY) said today it won FDA 510(k) clearance for its Radixact treatment delivery platform designed for image-guided radiotherapy treatments designed for cancer patients. The company said it also won FDA clearance for its Accuray Precision treatment planning system and iDMS data management system, components of its Radixact treatment platform. “The Radixact system builds upon the […]
IsoRay touts brachytherapy brain cancer trial
IsoRay (NYSE:ISR) today released results from a prospective trial of intraoperative brachytherapy using its Cesium-131 brachytherapy seeds, touting that 95% of treated tumors showed no regrowth at the operative site. The study examined the use of the IsoRay’s seeds for treating recurrent aggressive meningiomas by applying seeds embedded in collagen tiles directly to brain tissue after […]
Elekta inks U.S. brachytherapy distro deal with Kobold Medical.
Elekta (STO:EKTA B) said yesterday it inked a distribution deal with Kobold Medical to distribute its brachytherapy applicators within the U.S. Through the deal, Elekta will market and distribute 4 kobold applicators, as well as its prostate template, the company said. “We are pleased to offer our brachytherapy users in the United States these high quality […]
Sensus Healthcare closes $11m IPO
Sensus Healthcare (NSDQ:SRTSU) said today it closed its initial public offering, raising $11 million through the sale of 2.3 million units at $5.50 each. The offering included a fully-exercised underwriters option of an additional 300,000 units at the IPO price, Sensus said. Each share consists of a unit of stock and a 3-year warrant with an […]
Sensus Healthcare prices $11m IPO
Sensus Healthcare (NSDQ:SRTSU) priced an $11 million initial public offering yesterday, saying it plans to float 2 million shares at $5.50 apiece starting today. Boca Raton, Fla.-based Sensus said the offering, expected to close June 8, also includes a 300,000-unit over-allotment option for the IPO’s underwriters. Each share consists of a unit of stock and a 3-year […]